81365
Mowiol® 18-88
Mw ~130,000
Synonym(s):
Poly(vinyl alcohol)
Sign Into View Organizational & Contract Pricing
All Photos(1)
About This Item
Linear Formula:
[-CH2CHOH-]n
CAS Number:
MDL number:
UNSPSC Code:
12352104
NACRES:
NA.23
Recommended Products
form
crystals
Quality Level
mol wt
Mw ~130,000
extent of labeling
86.7-88.7 mol% hydrolysis
~2,700 polymerization
ign. residue
≤0.5%
viscosity
16-20 mPa.s, 4 % in H2O(20 °C)
InChI
1S/C2H4O/c1-2-3/h2-3H,1H2
InChI key
IMROMDMJAWUWLK-UHFFFAOYSA-N
Looking for similar products? Visit Product Comparison Guide
Application
Mowiol®18-88 is a polyvinyl alcohol (PVA) that is mainly used as a surfactant. It can be used as a polymeric matrix in the preparation of silver nanoparticles.
Legal Information
Mowiol is a registered trademark of Kuraray Europe GmbH
Storage Class Code
11 - Combustible Solids
WGK
WGK 1
Flash Point(F)
No data available
Flash Point(C)
No data available
Personal Protective Equipment
dust mask type N95 (US), Eyeshields, Gloves
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Customers Also Viewed
Photo-triggered release in polyamide nanosized capsules
AIP Conference Proceedings, 1599(1), 234-237 (2014)
Influence of polymeric surfactants on pesticidal suspension concentrates: dispersing ability, milling efficiency and stabilization power
Haas S, et al.
Colloids and Surfaces. A, Physicochemical and Engineering Aspects, 183(1), 785-793 (2001)
Photochemical synthesis of silver nanoparticles in polyvinyl alcohol matrices
Kutsenko AS and Granchak VM
Theoretical and Experimental Chemistry, 45(5), 313-318 (2009)
Feng-yong Liu et al.
Acta radiologica (Stockholm, Sweden : 1987), 54(1), 61-66 (2013-02-05)
Preoperative embolization of tumors is a well-established procedure that has been successfully applied in various clinical situations. Preoperative embolization can reduce the vascularity of tumors resulting in a clearer operative field, less difficult dissection, decreased blood loss, and, in some
Roger F Falkenstern-Ge et al.
Journal of bronchology & interventional pulmonology, 20(1), 58-62 (2013-01-19)
Emphysema is a progressive and irreversible disease for which there is no cure to date. The patients experience debilitating shortness of breath with repetitive exacerbations and poor quality of daily life. At present, patients with severe emphysema have limited treatment
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service